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ABSTRACT: Pharmaceutical compounds in surface waters are an emerging 
environmental concern due to their biological activity, which consequently present a new 
challenge for drinking water and wastewater treatment systems. In this work, diclofenac 
(DCF) and indomethacin (IDM) have been used as target molecules or templates in order 
to be removed by means of molecularly imprinted polymers (MIP). MIP-DCF and MIP-
IDM were synthesised and tested using two mathematical models, which are Lagergren and 
Thomas models. In addition, functional groups of the active functional sites and the target 
molecules have also been studied by using Fourier transform infrared spectroscopy. Both 
MIPs followed the Lagergren pseudo first order kinetic model. Comparing the original 
MIP-DCF and MIP-DCF after loading with DCF, differences in their functional groups 
were found. In conclusion, MIP-DCF and MIP-IDM work as good sorbents to recover 
these emerging pharmaceuticals persistent pollutants from water.
Keywords: Molecularly imprinted polymer, MIP, diclofenac, indomethacin, diclofenac 
recovery
1. INTRODUCTION
A few decades ago, emerging persistent pharmaceutical pollutants (EPPPs) have 
been introduced as one type of recalcitrant pollutant sources in water.1 Recent 
studies have demonstrated that, despite the relatively low concentrations of 
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pharmaceuticals in the environment (typically in sub-parts-per-billion levels), 
pharmaceuticals are of great concern due to their potential long-term adverse 
effects on humans and wildlife.2
Nowadays, there are many methods used for the recovery of pharmaceuticals, 
such as photocatalysis and sorbents, but they present some drawbacks, e.g., after 
photocatalysis the by-product generated may be more harmful than the parent 
compounds.3 There are many kinds of sorbents that have been studied, but not 
all the sorbents have the potential to recover the target molecules. In this work, 
molecularly imprinted polymers (MIPs) as a separation method is proposed and 
characterised. The polymeric matrices obtained using the imprinting technology 
are robust molecular recognition elements able to mimic natural recognition 
entities.4 MIPs are also good sorbents because of their porosity and their robustness 
properties. In this study, the removal of diclofenac (DCF) and indomethacin 
(IDM) have been carried out using MIPs, synthetised via bulk polymerisation with 
allylthiourea (AT) as the functional monomer and using DCF or IDM as template 
(MIP-DCF or MIP-IDM, respectively). DCF and IDM were detected using 
spectrophotometry.
To study the properties of the sorbents, MIPs have been tested in batch mode and 
continuous flow mode. In the batch mode, Lagergren model was used to describe 
the adsorption properties. However, in the continuous flow mode, Thomas model 
was used for the breakthrough study.  On the other side, functional groups can be 
used as a fingerprint for certain MIPs to show if the active functional sites work. 
However, there are a few articles reporting on this parameter which give important 
information about MIP development. ATR-FTIR has been used to observe the 
different types of MIPs and to study their functional sites. 
2. EXPERIMENTAL
2.1 Materials 
Indomethacin (IDM) was purchased from Sigma-Aldrich, Spain, with 98%–99% 
purity (TLC grade). Diclofenac-Na was from Cayman Chemical, United States 
with purity of more than 99%. Ethanol with 96% purity was acquired from 
Scharlau Chemical, Spain. Acetic acid was from J. T. Baker, United States with 
99.9% of purity, respectively, and HPLC grade. Acetonitrile (99% of purity HPLC 
grade) from VWR. Grace Alltech “Extract Clean” empty reservoirs with silica 
frits, 1.5 ml from Fisher Scientific, United States. 
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2.2 Synthesis of MIP-DCF and MIP-IDM
Synthesis of MIP-IDM and MIP-DCF were performed following the procedure of 
Kugimiya et al. with some modifications.5
2.3 Recovery Study
An amount of 10 mg MIP-IDM was weighed and placed into a 1.5 ml cartridge. 
Then, 1 ml of ethanol:water (75% v/v) was passed through it twice to activate 
the MIP-IDM. Next, 1 ml of water was added for 5 times to rinse out the ethanol 
residue. Afterwards, acetonitrile:water (5% v/v) was added twice for conditioning 
the MIP-IDM. Later, 1 ml of 15 µg ml−1 of IDM was added twice. The eluted 
solution was collected and analysed using a UV-vis spectrophotometer at 260 nm. 
After that, 1 ml of ethanol:water (75% v/v) was loaded twice into the cartridge 
and the collected solution was also analysed by UV spectrophotometry. The 
procedure was done in triplicate. The percentage of recovery was calculated using 
Equation 1, where Ci and Cf represent the analyte concentration for initial and final 
respectively:
% Recovery =
Cf – Ci × 100 (1)
Cf
Moreover, the recovery procedure mentioned above was done regenerating the 
same MIP and reusing it until 10 times (consecutive extractions) in order to 
evaluate the reuse of the MIP. The same procedure was performed by using MIP-
DCF as a sorbent and measuring the eluted solution at 280 nm for DCF analysis.
2.4 Kinetic Study
An amount of 10 mg of MIP-DCF was weighed and placed in 5 ml tubes. Then, 
2 ml of 5 mg l−1 DCF solution were poured into the tubes and covered using 
aluminium foil.6 Solutions were agitated for the required time up to 120 min and 
then filtered using a syringe filter (0.22 μm). The procedure was performed in 
triplicate and repeated for MIP-IDM using IDM solution. The calculated capacity 
(mg of compound/g of MIP) versus time was plotted following the Lagergren 
model.
2.5 Breakthrough Experiment – Continuous Flow Mode
Due to the immiscibility properties of DCF in water, total sorption capacity has 
been carried out in acetonitrile:water (5% v/v). An amount of 10 mg of MIP-DCF 
was accurately weighed and placed in a 1.5 ml cartridge. Next, 15 µg ml−1 of 
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DCF was prepared in acetonitrile:water (5% v/v) and the solution was loaded into 
the cartridge using a peristaltic pump at 1.67 ml min−1. The eluted solution was 
collected in fractions of 5 ml until 50 ml, then, in fractions of 50 ml until the 
absorbance measurements of the eluted solution reached a plateau. All the collected 
fractions were analysed by UV spectrophotometry. The procedure mentioned 
above was done in duplicate. The same methodology was repeated in the absence 
of MIP, in order to measure any other contribution to the elimination of the target 
compounds, i.e., sorption in cartridge or frits. Similar procedure was performed for 
IDM removal by MIP-IDM.
2.6 Attenuated Total Reflectance Fourier Transform Infrared Analysis 
ATR-FTIR has been used in this study to determine the functional groups in the 
original MIP-DCF and after loading with 2 ml of DCF solution (5 µg ml−1) via 
molecularly imprinted solid phase extraction (MISPE).
3. RESULTS AND DISCUSSION
3.1 Recovery Study and Lagergren Model
The ability to sorb-desorb for the synthetised MIPs were not significantly 
decreased after 10 cycles reaching almost 100% of recovery (Figure 1). The 
average percentage of recovery for the 10 cycles of IDM and DCF using MIP-IDM 
and MIP-DCF were 98 ± 3% and 97 ± 2% respectively.
From the kinetics, 100% removal was obtained in 3 min in batch mode. It is 
well accepted that two-parameter adsorption kinetic equations (Lagergren first-
order and second-order) are useful tools to describe the adsorption properties of a 
sorbent.7 The Lagergren pseudo first-order equation can be linearly expressed as 
Equation 2, where Qe and Qt are the adsorption capacities (mg of compound/g of 
sobent) of MIP at equilibrium and at time t, respectively; k1 is the first order rate 
constant. Figure 2 shows that both MIPs fitted to the Lagergren pseudo first order 
model. For further experimental procedure, MIP-DCF was used as a sorbent.
Ln (Qe − Qt) = LnQe − k1t (2)
3.2 Breakthrough Study
Breakthrough in column can be identified as the amount of influent solution 
passing through the bed before a maximum effluent concentration is reached. 
The ratio Ct (effluent concentration)/Co (influent concentration) is plotted against 
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IDMDCF
Figure 1: Percentage recovery for 10 regenerations of IDM and DCF using MIP-IDM and 
MIP-DCF as the sorbent respectively, via pre-packed cartridge with initial 
concentration of 15 µg ml−1 IDM and DCF, MIP mass:10 mg.
Figure 2: Adsorption capacities (Q) of MIP-IDM and MIP-DCF in front of time following 
Lagergren pseudo first order model plot.
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the time of the analyte solution loading as seen in Figure 3. As seen in the kinetic 
study, within 3 min the sorption uptake was higher than 80%, thus resulting in 
relatively fast attainment of breakthrough. Breakthrough and exhaustion are 
defined as normal when the ratios of effluent-to-influent concentration are between 
10% and 60%, respectively.8 In this work, the breakthrough point was reached at 
6 min and the exhaustion point at 270 min for MIP-DCF and 24 min and 210 min 
for MIP-IDM respectively. From Figure 3, it is seen that the ratio is about 60% and 
80% for MIP-DCF and MIP-IDM respectively. The methodology of adsorption in 
fixed bed cartridge by the breakthrough curves method proved to be a good option 
to study the separation of the pharmaceutical compounds in water.
Figure 3: Breakthrough curves from packed cartridges using MIP-DCF as sorbent for 
DCF removal and MIP-IDM as sorbent for IDM removal, using Thomas model 
versus time.
3.3 FTIR Analysis
The MIPs, original and after DCF loading, have been differentiated via ATR-FTIR 
and the spectra obtained could be used as a fingerprint in order to distinguish them 
as seen in Figures 4(a) and 4(b). N-H stretch functional group at 3000 nm−1 and 
C-N stretch bond at 1180 nm−1 found in original MIP (Figure 4(a)); OH broad peak 
at 3300 nm−1 found in MIP loaded with DCF (Figure 4(b)) due to –OH functional 
group from DCF bonded to MIP-DCF. Probably there is also N-H functional group 
that might contribute in this peak; C=O bond at 1750 nm−1 found in all MIPs; and 
C=C bond at 1650 nm−1 found in MIP loaded with DCF.
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Figure 4: Infrared spectrum of (a) original MIP-DCF and (b) MIP-DCF loaded with DCF. 
4. CONCLUSION
In conclusion, MIP-DCF and MIP-IDM have shown to be highly effective for the 
removal of the pharmaceutical compounds DCF and IDM, respectively. MIP is a 
promising analytical method for the removal of pharmaceuticals from water.
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